Matthias Miederer

机构：German Cancer Research Center, Johannes Gutenberg University Mainz, Heidelberg University, Helmholtz-Zentrum Dresden-Rossendorf, University Hospital Heidelberg, University Medical Center of the Johannes Gutenberg University Mainz, National Center for Tumor Diseases, University Hospital Carl Gustav Carus, Nationales Centrum für Tumorerkrankungen Dresden, Technische Universität Dresden · ORCID：0000-0001-5075-5995

发表论文 196 篇 · 总被引 5052 次 · h-index 30

代表论文

New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study (2026 · The Lancet Oncology · 被引 3)
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry (2026 · Journal of Nuclear Medicine · 被引 1)
FDG-PET/CT based small volume accelerated immuno chemoradiotherapy in locally advanced NSCLC (PACCELIO) – a randomized, open-label, multicenter phase II trial protocol (2026 · BMC Cancer · 被引 1)
Data publication: "Imaging triplets on two wheels" - ⁶¹Cu-, ⁶⁴Cu-, and ⁶⁸Ga-labeled bicyclic peptides targeting Nectin-4 enable high-contrast PET imaging of urothelial carcinoma and triple-negative breast cancer (2026 · RODARE)
Data publication: "Precision on two wheels" – Structural refinement of ⁶⁴Cu- and ⁶⁸Ga-labeled bicyclic peptides targeting nectin-4 for improved tumor imaging: from preclinical development to first-in-human application (2026 · RODARE)
Data publication: "Precision on two wheels" – Structural refinement of ⁶⁴Cu- and ⁶⁸Ga-labeled bicyclic peptides targeting nectin-4 for improved tumor imaging: from preclinical development to first-in-human application (2026 · RODARE)